No Data
No Data
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs
Innocan Pharma (INNO.CN), on Tuesday said a preliminary safety evaluation of Innocan's single injection and sustained-release LPT-CBD conducted on minipigs showed the animals demonstrated excellent dr
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
InnoCan Pharma Corp. (OTCQB:INNPF) (CSE:INNO) (FSE: IP4) an Israel-based cannabinoids-focused pharmaceutical company, announced its interim consolidated financial results Monday for the three months e
Innocan Pharma Reports First Quarter 2024 Results With Revenue Growth of Over 4X to $6.8 Million
InnoCan Pharma Brief: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain
04:02 PM EDT, 05/21/2024 (MT Newswires) -- InnoCan Pharma Brief: FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain
Innocan Pharma to Participate in the White Label World Expo on February 27-28th, 2024
InnoCan Pharma Brief: Says "Surge" in Revenue Primarily Attributable to "Robust" Sales Performance of Subsidiary, B.I. Sky Global Ltd.
04:02 PM EST, 11/29/2023 (MT Newswires) -- InnoCan Pharma Brief: Says "Surge" in revenue Primarily attributable to "Robust" sales performance of Subsidiary, B.I. Sky Global Ltd.